Cramer’s lightning round: Don’t sell Marvell Technology

Cramer’s lightning round: Don’t sell Marvell Technology


OptimizeRx Corp: “There’s not enough there at that company. … Can’t go there.”

SoFi Technologies Inc: “Here’s the problem. This thing was built as a way to be able to help on student loans, and when you get rid of your major product … it’s very hard to recommend the stock.”

Marvell Technology Inc: “That one’s been going down along with some others, and it’s the one that shouldn’t. … We are looking to buy back the stock we sold. Please do not sell Marvell Technology.”

Solid Power Inc: “Energy storage situations are very hard. … I can’t really own that stock.”



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More